SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Cempra Pharmaceuticals, Inc. Announces Initiation of CEM-102 Phase 2 Clinical Trial in Patients With Prosthetic Joint Infections
Your Message